CNS Pharmaceuticals, Inc.

Ownership Transactions Reported by 11 Insiders

Symbol
CNSP on Nasdaq
Industry
Pharmaceutical Preparations
Location
2100 West Loop South, Suite 900, Houston, TX

There are no Buy or Sell transactions made by insiders since 11/23/2024

CNS Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Waldemar Priebe 10%+ Owner $198K Dec 6, 2022
Cortice Biosciences, Inc. 10%+ Owner $172K Jul 30, 2024
Carl Anthony Evans Director $54.2K Apr 8, 2024
Amy Mahery Director Nov 17, 2025
Jeffry R. Keyes Director Nov 17, 2025
Andrzej Andraczke Director Sep 21, 2023
Bettina M. Cockroft Director Nov 17, 2025
Christopher Downs Chief Financial Officer Nov 17, 2025
John M. Climaco Chief Executive Officer, Director Nov 17, 2025
Faith L. Charles Director Nov 17, 2025
Jerzy Gumulka Director Nov 17, 2025

Recent Insider Transactions by Companies or Individuals for CNS Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.